Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$8.26+0.29 (+3.64%)
Close on Nov 17, 2026Market cap $424.04MP/E –Yield –
Prothena Corp Public price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Prothena Corp Public's price to book ratio was 1.6× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.6× to 7.4×, with a median of 2.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | −0.2 |
| 2025 | Dec 31, 2025 | 1.7× | +0.3 |
| 2024 | Dec 31, 2024 | 1.4× | −1.8 |
| 2023 | Dec 29, 2023 | 3.2× | −4.0 |
| 2022 | Dec 30, 2022 | 7.1× | +2.4 |
| 2021 | Dec 31, 2021 | 4.7× | +2.4 |
| 2020 | Dec 31, 2020 | 2.3× | +0.1 |
| 2019 | Dec 31, 2019 | 2.2× | +1.0 |
| 2018 | Dec 31, 2018 | 1.2× | −2.0 |
| 2017 | Dec 29, 2017 | 3.2× | −1.0 |
| 2016 | Dec 30, 2016 | 4.2× | −1.5 |
| 2015 | Dec 31, 2015 | 5.7× | +3.8 |
| 2014 | Dec 31, 2014 | 1.9× | −2.9 |
| 2013 | Dec 31, 2013 | 4.7× | – |
See a number that looks wrong?